Category: Diabetes

Introduction and Objective: Glycemic variability (GV) is associated with poor glycemic control and complications in patients with T2DM. The coefficient of variation (CV) derived from CGM has been widely used as a reliable measure of GV.Methods: A total of 773 patients with T2DM were included. A multivariate linear regression model was used to assess independent […]

Introduction and Objective: DKA at the time of first presentation of T1DM is preventable. The aim of this study was to determine the proportion of individuals with a new onset T1DM, by race and ethnicity, presenting with DKA in a large integrated healthcare system based in Northern California (Sutter Health).Methods: ICD-9 and ICD-10 codes were […]

Introduction and Objective: CGMs help millions of people manage their diabetes. These use passive sensors that have performance and usability limitations. IMS uses semiconductor and nano technologies to create a highly miniaturized electrochemical sensor, the CGM+. It uses a multi-sensor array and sends multiplexed data to an external transmitter, which processes and relays it to […]

Introduction and Objective: Effective diabetes management often relies on the use of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps. However, barriers to accessing and utilizing these tools can significantly hinder individuals with type 1 diabetes (T1D). To explore these challenges, we conducted focus groups and structured interviews with a diverse […]

Introduction and Objective: Prior work by the Michigan Collaborative for Type 2 Diabetes (MCT2D) demonstrated increased adherence to non-insulin guideline-directed medical therapy (NI-GDMT) for type 2 diabetes (T2D) over the past 4 years but insulin use remains unclear. We examined insulin use in MCT2D practices over this period.Methods: We analyzed pharmacy claims from 82,207 adults […]

Introduction and Objective: To investigate the prevalence of overweight or obesity among persons with type 1 diabetes (T1D) globally.Methods: Multiple databases were searched for observational studies reporting the prevalence of overweight or obesity in persons with T1D from the inception to March 2024. The pooled prevalences of overweight or obesity were calculated according to the […]

Introduction and Objective: The Stelo Glucose Biosensor offers real-time glucose data and insights to individuals not on insulin, with or without diabetes. This study assessed early user experiences to evaluate the impact of real-time glucose monitoring on glycemic outcomes and behavior in users with no diabetes (ND), prediabetes (PreD), or Type 2 Diabetes (T2D) during […]

Introduction and Objective: People living with type 1 diabetes (pwT1D) are at risk for micro and macrovascular complications, mental health issues, as well as higher risk for additional autoimmune diseases (AD+). We aimed to understand the association between additional ADs and T1D related physical and mental burdens in Canadian adults.Methods: This was a cross-sectional study […]

Introduction and Objective: Glucagon influences glucose tolerance by increasing nutrient-induced insulin secretion. After gastric bypass (GB), prandial glucagon levels rise, independent of the nutrient composition, and remain elevated in the latter phase of the meal, when glycemia dips below fasting level. Here, we investigated the effect of hyperglucagonemia (100-150 pg/ml), created by ‘exogenous glucagon infusion’, […]

Introduction and Objective: Studies suggest weight gain in type 1 diabetes (T1D) may parallel that of adults without diabetes. The impact of this on cardiometabolic risk factors in T1D is less known.Methods: Veterans with T1D in the Veterans Health Administration from January 1, 2022 to December 31, 2023 had BMI calculated using averaged heights and […]